42 USC 284m-1 - Pediatric Advisory Committee

U.S Code last checked for updates: Nov 22, 2024

§ 284m–1.

Pediatric Advisory Committee

(a)

In general

(b)

Purpose

(1)

In general

(2)

Matters included

The matters referred to in paragraph (1) include—

(A)

pediatric research conducted under sections 262, 284m, and 290b of this title and sections 351, 352, 355, 355a, 355c, 360(k), 360e, and 360j(m) of title 21;

(B)

identification of research priorities related to therapeutics (including drugs and biological products) and medical devices for pediatric populations and the need for additional diagnostics and treatments for specific pediatric diseases or conditions;

(C)

the ethics, design, and analysis of clinical trials related to pediatric therapeutics (including drugs and biological products) and medical devices; and

(D)

the development of countermeasures (as defined in section 360bbb–4(a) of title 21) for pediatric populations.

(c)

Composition

(d)

Continuation of Operation of Committee

(Pub. L. 107–109, § 14, Jan. 4, 2002, 115 Stat. 1419, as amended by Pub. L. 108–155, § 3(b)(2), Dec. 3, 2003, 117 Stat. 1941; Pub. L. 110–85, title III, § 306(b), title V, § 502(d), Sept. 27, 2007, 121 Stat. 865, 889; Pub. L. 112–144, title V, § 507(a), July 9, 2012, 126 Stat. 1045; Pub. L. 113–5, title III, § 307(c), Mar. 13, 2013, 127 Stat. 192; Pub. L. 117–286, § 4(a)(233), Dec. 27, 2022, 136 Stat. 4331.)

cite as: 42 USC 284m-1